KRAS and colorectal cancer: Recently, the Molecular Cancer Genetics Platform of Poitiers (French) has published interesting results about the clinicopathological features of every KRAS and NRAS mutation in a cohort of 1735 French colorectal cancer patients, enrolled from 28 hospital molecular genetics platforms throughout France [15].